Sutro Biopharma Overview

  • Founded
  • 2003
Founded
  • Status
  • Public
  • Employees
  • 204
Employees
  • Stock Symbol
  • STRO
Stock Symbol
  • Investments
  • 1
  • Share Price
  • $19.50
  • (As of Wednesday Closing)

Sutro Biopharma General Information

Description

Sutro Biopharma Inc is a clinical stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers.

Contact Information

Formerly Known As
Fundamental Applied Biology
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Delivery
Other Industries
Drug Discovery
Biotechnology
Stock Exchange
NAS
Primary Office
  • 310 Utah Avenue
  • Suite 150
  • South San Francisco, CA 94080
  • United States
+1 (650) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Sutro Biopharma Stock Performance

(As of Wednesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$19.50 $19.01 $12.03 - $28.30 $877M 46.1M 228K -$2.23

Sutro Biopharma Financials Summary

In Thousands,
USD
TTM 30-Jun-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 630,692 733,313 140,172 285,069
Revenue 68,810 42,722 42,736 38,419
EBITDA (73,450) (25,262) (50,691) (32,684)
Net Income (78,916) (32,128) (55,744) (35,317)
Total Assets 359,788 394,111 156,370 223,139
Total Debt 24,819 24,545 9,876 14,724
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Sutro Biopharma Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Sutro Biopharma‘s full profile, request access.

Request a free trial

Sutro Biopharma Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore Sutro Biopharma‘s full profile, request access.

Request a free trial

Sutro Biopharma Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Sutro Biopharma Inc is a clinical stage drug discovery, development, and manufacturing company. It is mainly engaged in
Drug Delivery
South San Francisco, CA
204 As of 2021
00000
000000 - 000 00000

0000000

in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occ
0000000000000
Cambridge, MA
000 As of 0000
00000
000000000 00000

00000 00

lore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliqui
0000000000000
Hayward, CA
000 As of 0000
00000
0.000 0000-00-00
000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Sutro Biopharma Competitors (113)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Mersana Therapeutics Formerly VC-backed Cambridge, MA 000 00000 000000000 00000
00000 00000000000 Formerly VC-backed Hayward, CA 000 00000 000000000 00000
0000000 00000000 Formerly VC-backed Cambridge, MA 00 00000 000000 - 000 00000
000000000 00000000 Formerly VC-backed Austin, TX 000 00000 00000000 00000
000000 00000000000 Formerly VC-backed South San Francisco, CA 000 00000 00000000 00000
You’re viewing 5 of 113 competitors. Get the full list »

Sutro Biopharma Patents

Sutro Biopharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20200405813-A1 Immunomodulator antibody drug conjugates and uses thereof Pending 10-Jun-2019 00000000000
EP-3852811-A1 Combination therapies with anti-folate receptor antibody conjugates Pending 17-Sep-2018 00000000000
EP-3774901-A1 Anti-bcma receptor antibodies, compositions comprising anti bcma receptor antibodies and methods of making and using anti-bcma antibodies Pending 26-Mar-2018 00000000000
US-20210130483-A1 Anti-bcma receptor antibodies, compositions comprising anti bcma receptor antibodies and methods of making and using anti-bcma antibodies Pending 26-Mar-2018 00000000000
US-20200147229-A1 Anti-folate receptor antibody conjugates, compositions comprising anti-folate receptor antibody conjugates, and methods of making and using anti-folate receptor antibody conjugates Pending 18-Sep-2017 A61K47/6425

Sutro Biopharma Executive Team (28)

Name Title Board Seat Contact Info
William Newell JD Chief Executive Officer & Board Member
Edward Albini Chief Financial Officer
Trevor Hallam Ph.D Chief Scientific Officer & President of Research
James Swartz Founder, Director and Scientific Advisory Board Member
Jane Chung Chief Commercial Officer
You’re viewing 5 of 28 executive team members. Get the full list »

Sutro Biopharma Board Members (19)

Name Representing Role Since
Connie Matsui Sutro Biopharma Chairman & Board Member 000 0000
Daniel Petree JD Self Board Member 000 0000
James Panek Sutro Biopharma Board Member 000 0000
John Freund MD Skyline Ventures Board Member 000 0000
Jon Wigginton MD Sutro Biopharma Board Member 000 0000
You’re viewing 5 of 19 board members. Get the full list »

Sutro Biopharma Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sutro Biopharma Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Sutro Biopharma‘s full profile, request access.

Request a free trial

Sutro Biopharma Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 23-Jul-2015 00000 00000 00 000.00 Drug Discovery 0000000 000000 00
To view Sutro Biopharma’s complete investments history, request access »

Sutro Biopharma Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
0000000 23-Jul-2015 00000 00000 00 000.00 Completed
  • 7 buyers
To view Sutro Biopharma’s complete exits history, request access »